Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 11, Pages 1336
Publisher
MDPI AG
Online
2019-10-31
DOI
10.3390/cells8111336
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion
- (2019) Zachary J. Farino et al. MOLECULAR PSYCHIATRY
- Serotonergic regulation of insulin secretion
- (2018) L. R. Cataldo Bascuñan et al. Acta Physiologica
- Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants
- (2018) Miriam Saiz-Rodríguez et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Hypothalamic AMPK and energy balance
- (2018) Miguel López EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Genetic polymorphisms of HTR2C ,LEP and LEPR on metabolic syndromes in patients treated with atypical antipsychotic drugs
- (2018) Apichaya Puangpetch et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder
- (2018) Kyle J. Burghardt et al. PHARMACOTHERAPY
- Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies
- (2018) Kyle J. Burghardt et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Obesity exacerbates the acute metabolic side effects of olanzapine
- (2018) Logan K. Townsend et al. PSYCHONEUROENDOCRINOLOGY
- The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
- (2018) Ranran Li et al. Frontiers in Pharmacology
- Clozapine-Induced Acute Hyperglycemia Is Accompanied with Elevated Serum Concentrations of Adrenaline and Glucagon in Rats
- (2018) Masashi Nagata et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Glucagon-like peptide-1 receptor-agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis
- (2018) Dan Siskind et al. DIABETES OBESITY & METABOLISM
- Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain
- (2018) Malgorzata Maciukiewicz et al. JOURNAL OF NEURAL TRANSMISSION
- Glucose and Insulin-Related Traits, Type 2 Diabetes and Risk of Schizophrenia: A Mendelian Randomization Study
- (2018) Zhiqiang Li et al. EBioMedicine
- The IRS/PI3K/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats
- (2018) Liying Ren et al. LIFE SCIENCES
- Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats
- (2017) P. Lazzari et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment
- (2017) Christina Power Sjo et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Fat Distribution in Schizophrenia Patients
- (2017) Mamta Sapra et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effect of a dosing-time on quetiapine-induced acute hyperglycemia in mice
- (2017) Snehal Kapse et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact
- (2017) Chantel Kowalchuk et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Clozapine as a Model for Antipsychotic Development
- (2017) Frederick C. Nucifora et al. Neurotherapeutics
- Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland
- (2017) Oddur Ingimarsson et al. NORDIC JOURNAL OF PSYCHIATRY
- Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia
- (2017) Laura N. Castellani et al. PSYCHONEUROENDOCRINOLOGY
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
- (2017) Christoph U. Correll et al. World Psychiatry
- Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy
- (2017) Babu Swathy et al. Epigenomics
- Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
- (2017) David A. Sykes et al. Nature Communications
- Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study
- (2017) J. Westman et al. Epidemiology and Psychiatric Sciences
- Impaired Glucose Homeostasis in First-Episode Schizophrenia
- (2017) Toby Pillinger et al. JAMA Psychiatry
- Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder
- (2017) Julie R. Larsen et al. JAMA Psychiatry
- A polygenic score for schizophrenia predicts glycemic control
- (2017) Han Cao et al. Translational Psychiatry
- MiRNAs of peripheral blood as the biomarker of schizophrenia
- (2017) Kuanjun He et al. HEREDITAS
- Genetically determined schizophrenia is not associated with impaired glucose homeostasis
- (2017) Renato Polimanti et al. SCHIZOPHRENIA RESEARCH
- Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats
- (2017) Xuemei Liu et al. Scientific Reports
- Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance
- (2016) Kyle J Burghardt et al. BIPOLAR DISORDERS
- Serotonin (5-HT) receptor 2b activation augments glucose-stimulated insulin secretion in human and mouse islets of Langerhans
- (2016) Hedvig Bennet et al. DIABETOLOGIA
- Mental disorder diagnoses among children and adolescents who use antipsychotic drugs
- (2016) Ragnar Nesvåg et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- H1-histamine receptor affinity predicts weight gain with antidepressants
- (2016) Virginio Salvi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Brain stem as a target site for the metabolic side effects of olanzapine
- (2016) Imran J. Anwar et al. JOURNAL OF NEUROPHYSIOLOGY
- Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives
- (2016) Jaya L. Padmanabhan et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A preliminary analysis of microRNA-21 expression alteration after antipsychotic treatment in patients with schizophrenia
- (2016) Sheng-dong Chen et al. PSYCHIATRY RESEARCH
- Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis
- (2016) Jian-Ping Zhang et al. SCHIZOPHRENIA BULLETIN
- In vitro/vivo studies towards mechanisms of risperidone-induced oxidative stress and the protective role of coenzyme Q10 and N-acetylcysteine
- (2016) Aziz Eftekhari et al. TOXICOLOGY MECHANISMS AND METHODS
- Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
- (2016) Davy Vancampfort et al. World Psychiatry
- Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism
- (2016) Takuya Nagashima et al. Scientific Reports
- In vitro/vivo studies towards mechanisms of risperidone-induced oxidative stress and the protective role of coenzyme Q10 and N-acetylcysteine
- (2016) Aziz Eftekhari et al. TOXICOLOGY MECHANISMS AND METHODS
- Islet-specific monoamine oxidase A and B expression depends on MafA transcriptional activity and is compromised in type 2 diabetes
- (2015) Elvira Ganic et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends
- (2015) Louise Carton et al. CURRENT PHARMACEUTICAL DESIGN
- Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications
- (2015) Cenk Tek et al. Early Intervention in Psychiatry
- Functional Role of Serotonin in Insulin Secretion in a Diet-Induced Insulin-Resistant State
- (2015) Kyuho Kim et al. ENDOCRINOLOGY
- Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic
- (2015) B. Chiliza et al. EUROPEAN PSYCHIATRY
- Increased lean body mass as an early indicator of olanzapine-induced weight gain in healthy men
- (2015) Elsa Daurignac et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Metformin attenuates olanzapine-induced hepatic, but not peripheral insulin resistance
- (2015) Gary J Remington et al. JOURNAL OF ENDOCRINOLOGY
- Hypothalamic–pituitary–adrenal system, neurotrophic factors and clozapine response
- (2015) Marina Mitjans et al. Pharmacogenetics and Genomics
- Involvement of oxidative stress and mitochondrial/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes
- (2015) Aziz Eftekhari et al. XENOBIOTICA
- Antipsychotics inhibit glucose transport: Determination of olanzapine binding site inStaphylococcus epidermidis glucose/H+ symporter
- (2015) Petr Babkin et al. FEBS Open Bio
- RNA Sequencing Reveals a Slow to Fast Muscle Fiber Type Transition after Olanzapine Infusion in Rats
- (2015) Christopher J. Lynch et al. PLoS One
- Dopamine signaling in food addiction: role of dopamine D2 receptors
- (2014) Ja-Hyun Baik BMB Reports
- Olanzapine-Activated AMPK Signaling in the Dorsal Vagal Complex Is Attenuated by Histamine H1 Receptor Agonist in Female Rats
- (2014) Meng He et al. ENDOCRINOLOGY
- MicroRNA-9 and MicroRNA-326 Regulate Human Dopamine D2 Receptor Expression, and the MicroRNA-mediated Expression Regulation Is Altered by a Genetic Variant
- (2014) Sandra Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic variation in theGCGand in theGLP1Rgenes and antipsychotic-induced weight gain
- (2014) Eva J Brandl et al. PHARMACOGENOMICS
- No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sample
- (2014) Tim Moons et al. PHARMACOGENOMICS
- Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis
- (2014) Ichiro Kusumi et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- The activation of the Akt/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect
- (2014) G. C. Smith et al. PSYCHOPHARMACOLOGY
- Clozapine directly increases insulin and glucagon secretion from islets: Implications for impairment of glucose tolerance
- (2014) G.C. Smith et al. SCHIZOPHRENIA RESEARCH
- Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial
- (2014) Timothy L. Ramsey et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic Induced Weight Gain: Genetics, Epigenetics, and Biomarkers Reviewed
- (2014) Tahireh A. Shams et al. Current Psychiatry Reports
- Clozapine, a Fast-Off-D2 Antipsychotic
- (2013) Philip Seeman ACS Chemical Neuroscience
- Central administration of an orexin receptor 1 antagonist prevents the stimulatory effect of Olanzapine on endogenous glucose production
- (2013) Elodie M. Girault et al. BRAIN RESEARCH
- The Antipsychotic Olanzapine Induces Apoptosis in Insulin-secreting Pancreatic β Cells by Blocking PERK-mediated Translational Attenuation
- (2013) Riwa Ozasa et al. CELL STRUCTURE AND FUNCTION
- Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease
- (2013) Karen L. Teff et al. DIABETES
- Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5′-monophosphate-activated protein kinase
- (2013) M. Ikegami et al. DIABETES OBESITY & METABOLISM
- The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity
- (2013) C Cuerda et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: An animal model
- (2013) Margaret K. Hahn et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Exploratory study on association of genetic variation inTBC1D1with antipsychotic-induced weight gain
- (2013) Eva J. Brandl et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats
- (2013) H. N. Boyda et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Minireview: Novel Aspects of M3Muscarinic Receptor Signaling in Pancreatic β-Cells
- (2013) Kenichiro Nakajima et al. MOLECULAR ENDOCRINOLOGY
- Chronic effects of clozapine administration on insulin resistance in rats: Evidence for adverse metabolic effects
- (2013) Mohamed M. El-Seweidy et al. PATHOLOGY RESEARCH AND PRACTICE
- Serotonin Receptor 2C and Insulin Secretion
- (2013) Qiang Zhang et al. PLoS One
- Clozapine-Induced Mitochondria Alterations and Inflammation in Brain and Insulin-Responsive Cells
- (2013) Verόnica Contreras-Shannon et al. PLoS One
- Serotonin regulates glucose-stimulated insulin secretion from pancreatic cells during pregnancy
- (2013) M. Ohara-Imaizumi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Second-Generation Antipsychotics Cause a Rapid Switch to Fat Oxidation That Is Required for Survival in C57BL/6J Mice
- (2013) C. M. Klingerman et al. SCHIZOPHRENIA BULLETIN
- Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE Study
- (2013) Timothy L. Ramsey et al. SCHIZOPHRENIA RESEARCH
- Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: An animal model
- (2013) Melanie Dawn Guenette et al. SCHIZOPHRENIA RESEARCH
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls
- (2013) Davy Vancampfort et al. World Psychiatry
- Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways
- (2013) V Mondelli et al. Translational Psychiatry
- The Rab-GTPase-activating protein TBC1D1 regulates skeletal muscle glucose metabolism
- (2012) Ferenc Szekeres et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain
- (2012) Anil K. Malhotra ARCHIVES OF GENERAL PSYCHIATRY
- The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study
- (2012) Joseph C. Ratliff et al. COMPREHENSIVE PSYCHIATRY
- Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: Role of FOXA1 and mitochondrial citrate carrier
- (2012) A. Menga et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial
- (2012) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro
- (2012) Alberto Canfrán-Duque et al. JOURNAL OF LIPID RESEARCH
- Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats
- (2012) Heidi Boyda et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- The blood concentration and organ distribution of haloperidol at therapeutic and toxic doses in severe fatty liver disease
- (2012) Mayumi Ikemura et al. Legal Medicine
- Dopamine Synthesis and D3 Receptor Activation in Pancreatic β-Cells Regulates Insulin Secretion and Intracellular [Ca2+] Oscillations
- (2012) Alessandro Ustione et al. MOLECULAR ENDOCRINOLOGY
- Dopamine-Mediated Autocrine Inhibitory Circuit Regulating Human Insulin Secretionin Vitro
- (2012) Norman Simpson et al. MOLECULAR ENDOCRINOLOGY
- Acute Peripheral but Not Central Administration of Olanzapine Induces Hyperglycemia Associated with Hepatic and Extra-Hepatic Insulin Resistance
- (2012) Elodie M. Girault et al. PLoS One
- Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
- (2012) Kieran J. Davey et al. PSYCHOPHARMACOLOGY
- Antipsychotics, dopamine D2 receptor occupancy and clinical improvement in schizophrenia: A meta-analysis
- (2012) Zeynep Yilmaz et al. SCHIZOPHRENIA RESEARCH
- Mammalian Triacylglycerol Metabolism: Synthesis, Lipolysis, and Signaling
- (2011) Rosalind A. Coleman et al. CHEMICAL REVIEWS
- A Novel Mechanism for Regulating Hepatic Glycogen Synthesis Involving Serotonin and Cyclin-Dependent Kinase-5
- (2011) S. J. Tudhope et al. DIABETES
- Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels
- (2011) Katrina Weston-Green et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Clozapine impairs insulin action by up-regulating AKT phosphorylation and Ped/Pea-15 protein abundance
- (2011) Fabio Panariello et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA dysregulation in schizophrenia
- (2011) Natalie J. Beveridge et al. NEUROBIOLOGY OF DISEASE
- Association between the GIPR gene and the insulin level after glucose loading in schizophrenia patients treated with olanzapine
- (2011) S Ono et al. PHARMACOGENOMICS JOURNAL
- Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation
- (2011) Johan Fernø et al. PLoS One
- A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers
- (2011) Vance L. Albaugh et al. PLoS One
- Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: An animal model
- (2011) Margaret Hahn et al. SCHIZOPHRENIA RESEARCH
- Dopamine D2 Occupancy as a Biomarker for Antipsychotics: Quantifying the Relationship with Efficacy and Extrapyramidal Symptoms
- (2010) Rik de Greef et al. AAPS Journal
- Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats
- (2010) Katrina Weston-Green et al. BEHAVIOURAL BRAIN RESEARCH
- Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
- (2010) Richard Mailman et al. CURRENT PHARMACEUTICAL DESIGN
- Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance
- (2010) P. J. F. Martins et al. DIABETES
- Activation ofN-Methyl-d-aspartate (NMDA) Receptors in the Dorsal Vagal Complex Lowers Glucose Production
- (2010) Carol K. L. Lam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clozapine activates AMP-activated protein kinase (AMPK) in C2C12 myotube cells and stimulates glucose uptake
- (2010) Ji Hae Kim et al. LIFE SCIENCES
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
- (2010) Jimmi Nielsen et al. NEUROPSYCHOPHARMACOLOGY
- Atypical Antipsychotics Rapidly and Inappropriately Switch Peripheral Fuel Utilization to Lipids, Impairing Metabolic Flexibility in Rodents
- (2010) Vance L. Albaugh et al. SCHIZOPHRENIA BULLETIN
- Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics
- (2010) Ya Mei Bai et al. SCHIZOPHRENIA RESEARCH
- Hepatic Muscarinic Acetylcholine Receptors Are Not Critically Involved in Maintaining Glucose Homeostasis in Mice
- (2009) Jian H. Li et al. DIABETES
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine
- (2009) Arzu Gunes et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- 30 Days of Continuous Olanzapine Infusion Determines Energy Imbalance, Glucose Intolerance, Insulin Resistance, and Dyslipidemia in Mice
- (2009) Roberto Coccurello et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Olanzapine, not resperidone, exacerbates β-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them
- (2009) Sunmin Park et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model
- (2009) Araba F. Chintoh et al. SCHIZOPHRENIA RESEARCH
- Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: Implications for glucose metabolism and food choice behaviour
- (2009) Greg C. Smith et al. SCHIZOPHRENIA RESEARCH
- Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat
- (2008) G. C. Smith et al. DIABETOLOGIA
- Insulin Resistance and Decreased Glucose-Stimulated Insulin Secretion After Acute Olanzapine Administration
- (2008) Araba F. Chintoh et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Chlorpromazine attenuates pancreatic β-cell function and mass through IRS2 degradation, while exercise partially reverses the attenuation
- (2008) S. Park et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacokinetics and time-course of D2 receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients
- (2008) AM Catafau et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of olanzapine on glucose transport, proliferation and survival in C2C12 myoblasts
- (2008) Giovanni Tulipano et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Insulin resistance following continuous, chronic olanzapine treatment: An animal model
- (2008) Araba F. Chintoh et al. SCHIZOPHRENIA RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started